CN101919887A - 一种治疗银屑病的药物及其制备方法 - Google Patents
一种治疗银屑病的药物及其制备方法 Download PDFInfo
- Publication number
- CN101919887A CN101919887A CN2010102282856A CN201010228285A CN101919887A CN 101919887 A CN101919887 A CN 101919887A CN 2010102282856 A CN2010102282856 A CN 2010102282856A CN 201010228285 A CN201010228285 A CN 201010228285A CN 101919887 A CN101919887 A CN 101919887A
- Authority
- CN
- China
- Prior art keywords
- medicine
- cases
- water
- carapax trionycis
- fructus mume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 229940079593 drug Drugs 0.000 title claims abstract description 8
- 238000002360 preparation method Methods 0.000 title claims description 16
- 201000004681 Psoriasis Diseases 0.000 title abstract description 22
- 241000426256 Cyanotis Species 0.000 claims abstract description 49
- 210000000582 semen Anatomy 0.000 claims abstract description 31
- 210000000576 arachnoid Anatomy 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 230000001185 psoriatic effect Effects 0.000 claims description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000002994 raw material Substances 0.000 claims description 23
- UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 13
- 239000008395 clarifying agent Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000006187 pill Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 8
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 claims description 6
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 6
- 206010016825 Flushing Diseases 0.000 claims description 6
- 230000000274 adsorptive effect Effects 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 6
- 238000011010 flushing procedure Methods 0.000 claims description 6
- 238000004064 recycling Methods 0.000 claims description 6
- 229920005989 resin Polymers 0.000 claims description 6
- 239000011347 resin Substances 0.000 claims description 6
- 240000008042 Zea mays Species 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 3
- 230000004087 circulation Effects 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 235000013305 food Nutrition 0.000 abstract description 17
- 206010040882 skin lesion Diseases 0.000 abstract description 14
- 231100000444 skin lesion Toxicity 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 12
- 230000036541 health Effects 0.000 abstract description 5
- 230000001976 improved effect Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 241000270666 Testudines Species 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 16
- 241000255789 Bombyx mori Species 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 6
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 4
- 108010036949 Cyclosporine Proteins 0.000 description 4
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 4
- 235000011158 Prunus mume Nutrition 0.000 description 4
- 244000018795 Prunus mume Species 0.000 description 4
- 229960001265 ciclosporin Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229960000485 methotrexate Drugs 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 3
- 229960005339 acitretin Drugs 0.000 description 3
- IHUNBGSDBOWDMA-AQFIFDHZSA-N all-trans-acitretin Chemical compound COC1=CC(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1C IHUNBGSDBOWDMA-AQFIFDHZSA-N 0.000 description 3
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 3
- 238000005266 casting Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000736919 Pelodiscus sinensis Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000011262 co‐therapy Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000010429 evolutionary process Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 238000001126 phototherapy Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 230000002110 toxicologic effect Effects 0.000 description 2
- 231100000027 toxicology Toxicity 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010012455 Dermatitis exfoliative Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 208000003367 Hypopigmentation Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010027145 Melanocytic naevus Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 description 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037575 Pustular psoriasis Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 241001482311 Trionychidae Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000008649 adaptation response Effects 0.000 description 1
- LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 1
- 229960002170 azathioprine Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003425 hypopigmentation Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- VHOGYURTWQBHIL-UHFFFAOYSA-N leflunomide Chemical compound O1N=CC(C(=O)NC=2C=CC(=CC=2)C(F)(F)F)=C1C VHOGYURTWQBHIL-UHFFFAOYSA-N 0.000 description 1
- 229960000681 leflunomide Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102282856A CN101919887B (zh) | 2010-07-16 | 2010-07-16 | 一种治疗银屑病的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102282856A CN101919887B (zh) | 2010-07-16 | 2010-07-16 | 一种治疗银屑病的药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101919887A true CN101919887A (zh) | 2010-12-22 |
CN101919887B CN101919887B (zh) | 2012-05-23 |
Family
ID=43335271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102282856A Active CN101919887B (zh) | 2010-07-16 | 2010-07-16 | 一种治疗银屑病的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101919887B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5609873A (en) * | 1992-08-25 | 1997-03-11 | Lvmh Recherche | Use of an ecdysteroid for the preparation of cosmetic or dermatological compositions intended, in particular, for strengthening the water barrier function of the skin or for the preparation of a skin cell culture medium, as well as to the compositions |
CN1292283A (zh) * | 1999-07-03 | 2001-04-25 | 王淑贞 | 一种具有治疗作用的美容湿敷面膜及其制备方法 |
CN1977960A (zh) * | 2005-12-08 | 2007-06-13 | 李国栋 | 一种治疗银屑病的中药 |
-
2010
- 2010-07-16 CN CN2010102282856A patent/CN101919887B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5609873A (en) * | 1992-08-25 | 1997-03-11 | Lvmh Recherche | Use of an ecdysteroid for the preparation of cosmetic or dermatological compositions intended, in particular, for strengthening the water barrier function of the skin or for the preparation of a skin cell culture medium, as well as to the compositions |
CN1292283A (zh) * | 1999-07-03 | 2001-04-25 | 王淑贞 | 一种具有治疗作用的美容湿敷面膜及其制备方法 |
CN1977960A (zh) * | 2005-12-08 | 2007-06-13 | 李国栋 | 一种治疗银屑病的中药 |
Non-Patent Citations (1)
Title |
---|
《西南林学院学报》 20030630 朱向东 等 从露水草中提取纯化beta-蜕皮激素工艺研究 第23-25页 9 第23卷, 第2期 * |
Also Published As
Publication number | Publication date |
---|---|
CN101919887B (zh) | 2012-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102205108A (zh) | 一种治疗胃溃疡的中药制剂及其制备方法 | |
CN101972386A (zh) | 一种治疗糖尿病痛风的中药 | |
CN103749824A (zh) | 一种绞股蓝降糖降压保健茶及其制备方法 | |
CN102940742B (zh) | 一种治疗腰椎管狭窄症中药组合物 | |
CN102526639B (zh) | 治疗高血脂症的中药组合物及其制备方法 | |
CN101919887B (zh) | 一种治疗银屑病的药物及其制备方法 | |
CN106692886A (zh) | 一种用于治疗肝豆状核变性的中药组合物及其制备方法 | |
CN101961448A (zh) | 一种治疗糖尿病痛风的中药 | |
CN101869700B (zh) | 一种治疗肿瘤的中药口服液及其制备方法 | |
CN101797371B (zh) | 一种用于减肥按摩的药物组合物 | |
CN104096170B (zh) | 一种外用减肥的超微粉中药及其制备方法 | |
CN105381168B (zh) | 一种腰痛宁药物及其制备方法 | |
CN109200250A (zh) | 一种治疗乳腺癌的中药组合物及其制备方法 | |
CN109463625A (zh) | 一种荞麦核桃消炎食品冲料及其制备方法 | |
CN107661391A (zh) | 治疗乳腺增生的瑶医外用制剂及其制备方法 | |
CN102698202A (zh) | 一种用于治疗胆结石的中药组合物及其制备方法和应用 | |
CN102450587A (zh) | 治疗习惯性便秘、完腹胀痛的活血润肠粥及制备方法 | |
CN104645244A (zh) | 一种治疗动脉硬化症的中药组合物 | |
CN104857371A (zh) | 一种治疗结肠癌的药物及其制备方法 | |
CN1264566C (zh) | 一种治疗前列腺疾病的贴脐药 | |
CN104491527B (zh) | 一种治疗泌尿系感染的中药冲剂 | |
CN103751675B (zh) | 用于治疗猪消化不良的药物及其制备方法 | |
CN100551399C (zh) | 复方卡力孜然酊在制药中的应用 | |
CN102266483B (zh) | 一种治疗冠心病的中药组合物及其制备方法 | |
CN102671149B (zh) | 治疗痢疾鸦胆子中药口服液及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: YICHANG YIKANG DERMATOLOGY HOSPITAL LLC Free format text: FORMER OWNER: YICHANG WUJIAGANG YIKANG INSTITUTE OF DERMATOLOGY Effective date: 20150416 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150416 Address after: 443000 No. 40, the Yellow River Road, Yichang, Hubei Patentee after: Yichang Yikang Dermatology Hospital limited liability company Patentee after: Xiao Zhi Address before: 443000 No. 367, Yiling Road, Yichang, Hubei Patentee before: Yichang Wujiagang Yikang Institute of Dermatology Patentee before: Xiao Zhi |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171204 Address after: 443000 Yiling Avenue, Xiling District, Yichang, Hubei Province, -204 130, -204 Patentee after: Xiao Zhi Address before: 443000 No. 40, the Yellow River Road, Yichang, Hubei Co-patentee before: Xiao Zhi Patentee before: Yichang Yikang Dermatology Hospital limited liability company |
|
TR01 | Transfer of patent right |
Effective date of registration: 20171215 Address after: 443000 No. 40, the Yellow River Road, Yichang, Hubei Patentee after: Yichang Yikang Dermatology Hospital limited liability company Address before: 443000 Yiling Avenue, Xiling District, Yichang, Hubei Province, -204 130, -204 Patentee before: Xiao Zhi |
|
TR01 | Transfer of patent right |